Rpg Life Sciences share price

High risk
  • 49%Low risk
  • 49%Moderate risk
  • 49%Balanced risk
  • 49%High risk
  • 49%Extreme risk
  • ₹2,348.50(-2.32%)
    June 17, 2025 15:29:38 PM IST
    • NSE
    • BSE
  • Vol : 38.36K (NSE + BSE)
    Last 20 day avg : 27.69 K

Rpg Life Sciences is trading -2.32% lower at Rs 2,348.50 as compared to its last closing price. Rpg Life Sciences has been trading in the price range of 2,440.00 & 2,328.75. Rpg Life Sciences has given 7.96% in this year & 8.25% in the last 5 days. Rpg Life Sciences has TTM P/E ratio 20.59 as compared to the sector P/E of 23.94.The company posted a net profit of 117.35 Crores in its last quarter.Listed peers of Rpg Life Sciences include Dishman Carbogen Amcis (-5.00%), Aarti Drugs (-2.65%), Rpg Life Sciences (-2.32%).The Mutual Fund holding in Rpg Life Sciences was at 3.53% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Rpg Life Sciences was at 1.46% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 18, 2025, 02:52 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.85
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    7.35
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    21.28
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.36
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
2,328.75
Highest
2,440.00
52 week range
Lowest
1,457.00
Highest
2,976.70
Rpg Life Sciences News
Rpg Life Sciences Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 12.68% from Rs 143.09 crore to Rs 126.99 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 786.33% from Rs 13.24 crore to Rs 117.35 crore, year-on-year
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Rpg Life Sciences Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 2,379.10
  • R2
  • 2,574.55
  • R3
  • 2,709.10
Pivot2,244.55
  • S1
  • 2,049.10
  • S2
  • 1,914.55
  • S3
  • 1,719.10
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Rpg Life Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dishman Carbogen Amcis
Neutral
260.55-5.004,089.46249.600.74-23.83
Aarti Drugs
Neutral
450.00-2.654,107.1525.193.080.2220.87
Rpg Life Sciences
Bullish
2,348.50-2.323,915.4533.567.480.83-
Advanced Enzyme Technologies
Moderately Bullish
339.300.793,792.1928.772.651.541.47
Gufic Biosciences
Bearish
369.60-0.283,703.7653.356.190.0324.97
Rpg Life Sciences Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Rpg Life Sciences is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 72.95%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.16 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 0.06 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Quant Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 32.84
    • % of AUM 7.87
    WhiteOak Capital Pharma and Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 3.61
    • % of AUM 1.09
    Mirae Asset Multicap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 36.34
    • % of AUM 0.98
    Motilal Oswal Quant Fund Regular Growth
    NA
    • Amount Invested (Cr.) 0.78
    • % of AUM 0.54
    Quant Active Fund Growth
    4/5
    • Amount Invested (Cr.) 38.46
    • % of AUM 0.39
    Rpg Life Sciences Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-04-28Audited Results & Final Dividend
    2025-01-24Quarterly Results
    2024-11-07Quarterly Results
    2024-07-19Quarterly Results
    2024-04-30Audited Results & Final Dividend
    About the company Rpg Life Sciences
    • IndustryBiotechnology & Drugs
    • ISININE105J01010
    • BSE Code532983
    • NSE CodeRPGLIFE
    RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The International Formulations business operates in the generics and branded generics space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Lamotrigine, and others.
    • Management Info
    • Sheetal GabaChief Human Resources Officer
    • Rajesh ShirambekarHead - Legal, Compliance Officer, Company Secretary
    • Mahesh NarayanaswamyVice President - Finance
    • Ashok NairManaging Director, Director
    Rpg Life Sciences Share Price FAQs

    Rpg Life Sciences is trading at 2348.50 as on Tue Jun 17 2025 09:59:38. This is -2.32% lower as compared to its previous closing price of 2404.25.

    The market capitalization of Rpg Life Sciences is 3915.45 Cr as on Tue Jun 17 2025 09:59:38.

    The 52 wk high for Rpg Life Sciences is 2976.70 whereas the 52 wk low is 1457.00

    Rpg Life Sciences can be analyzed on the following key metrics -

    • TTM P/E: 20.59
    • Sector P/E: 23.94
    • Dividend Yield: 0.85%
    • D/E ratio: -

    Rpg Life Sciences reported a net profit of 183.24 Cr in 2025.

    The Mutual Fund Shareholding was 3.53% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Rpg Life Sciences QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Rpg Life Sciences share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.